Skip Navigation Links

2022 Regular Session
HB640   by Representative Mark Wright      

VACCINES/VACCINATION:  Provides relative to vaccines and vaccine-related pharmaceuticals produced with aborted human fetal-derived cells or human embryonic-derived cells (EGF NO IMPACT See Note)

Current Status:  Subject to call - House final passage

Skip Navigation Links
TextExpand Text
AmendmentsExpand Amendments
DigestsExpand Digests
NotesExpand Notes
VotesExpand Votes
AuthorsExpand Authors

 Date   ChamberJournal
Action sort history by ascending dates
05/09H32  Read by title, amended, returned to the calendar.
05/09H32  Called from the calendar.
05/05H  Scheduled for floor debate on 05/09/2022.
05/05H29  Notice given.
05/02H34  Read by title, returned to the calendar.
05/02H34  Called from the calendar.
04/27H  Scheduled for floor debate on 05/02/2022.
04/27H33  Notice given.
04/27H33  Read by title, returned to the calendar.
04/27H33  Called from the calendar.
04/26H  Scheduled for floor debate on 04/27/2022.
04/26H17  Notice given.
04/26H17  Read by title, returned to the calendar.
04/20H  Scheduled for floor debate on 04/26/2022.
04/18H21  Read by title, amended, ordered engrossed, passed to 3rd reading.
04/13H23  Reported with amendments (7-5).
03/14H75  Read by title, under the rules, referred to the Committee on Health and Welfare.
03/04H  First appeared in the Interim Calendar on 3/4/2022.
03/04H  Under the rules, provisionally referred to the Committee on Health and Welfare.
03/04H  Prefiled.

If you experience any technical difficulties navigating this website, click here to contact the webmaster.
P.O. Box 94062 (900 North Third Street) Baton Rouge, Louisiana 70804-9062